NCT04307693View on ClinicalTrials.gov

Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)

PHASE2TerminatedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
COVID-19
Interventions
DRUG

Lopinavir/ritonavir

Lopinavir / Ritonavir tablet

DRUG

Hydroxychloroquine sulfate

Hydroxychloroquine sulfate tablet

Trial Locations (1)

138-736

Asan Medical Center, University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT04307693 - Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) | Biotech Hunter | Biotech Hunter